-
Post-election pressures complicate US and Israeli decisions on Iran
-
South African voters report smoother local election but declining IEC trust
-
UN members approve talks on treaty protocol against environmental crime
-
Dolly Parton museum and Nashville hotel open after singer’s death
-
Family-run West Sussex beach café prepares for first winter season
-
George and Amal Clooney attend New York political-comedy reading
-
CT scans reveal health and burial clues from Egypt’s Braided Lady mummy
-
British buyers pay substantial premiums for period-home appearance
-
Oxford faces complaints over lecturer’s classroom attire
-
Thomas Markle released to house arrest after child-abuse-image charge
-
Kyren Wilson and John Higgins reach International Championship snooker final
-
Dawn of War 4 developers chose Adeptus Mechanicus for tactical variety
-
New Zealand and Tonga meet for place in Rugby League World Cup final
-
Italy face unbeaten South Africa in Turin Nations Championship match
-
Reports of unsafe AI-toy responses renew calls for child-safety rules
-
ChatGPT interactive interface feature tested across six custom tools
-
Juneau food network combines difficult supply routes with deep sharing traditions
-
Freshways milk-price cut deepens pressure on UK dairy farms
-
India climbs green-transition ranking after first emissions decline in 25 years
-
Labour and National remain virtually tied as New Zealand vote count advances
-
Trump names Stephen Miller as White House chief of staff after midterm losses
-
The Good Daughter adapts Karin Slaughter thriller with Rose Byrne and Meghann Fahy
-
Restored Albanian tower houses anchor new rural tourism trail
-
Heavy-lift drone evacuates wounded Ukrainian soldier from frontline kill zone
-
Sonia Gandhi reflects on family tragedy and reluctant political career
-
Morrison says West Brom recovered after pressure from successive derby losses
-
Pope Leo begins three-country South American tour in Uruguay
-
Britain considers 2027 state visit for Ukraine’s Zelensky
-
Khawaja says entire Australia camp knew of 2018 ball-tampering plan
-
Anna Miltina Confronted with Racism Allegations on ProSieben Show
-
November Foraging Guide: Edible Mushrooms and Critical Safety Protocols
-
German Auto Giants Face Existential Crisis as China Sales Plummet
-
Microsoft Updates Xbox PC App with 60% Faster Startup and Redesigned Interface
-
Cause of Death Revealed for 'Ellen' Producer Matthew Wright
-
Early Polar Vortex Disruption Creates Uncertain Winter Outlook for Pennsylvania
-
Fusion Power, Global Capital, Branded Streaming and Neurology Breakthroughs: New to The Street Show #779 Premieres Tonight on Bloomberg Television
-
DEA Marijuana Rescheduling Hearing Closes With Government Not Meeting Its Burden Of Proof?
-
How to Enjoy Luxury Experiences on a Budget
Conflicting US rulings leave fate of abortion pill in doubt
Conflicting rulings by two federal judges have left the future of abortion pills in the United States deeply uncertain, likely placing the divisive issue squarely in the lap of the Supreme Court.
A ruling Friday by federal judge Matthew Kacsmaryk in Texas banned the widely used drug mifepristone (RU 486) nationwide, boosting conservatives' efforts to further restrict abortion rights after the Supreme Court last year allowed states to prohibit them.
The unprecedented rejection of a drug approved in 2000 by the US Food and Drug Administration (FDA) -- and found safe by scientific consensus -- sparked outrage on the political left.
Kacsmaryk, in his ruling, adopted language used by abortion opponents, referring to abortion providers as "abortionists" and saying the drug was used to "kill the unborn human."
His ruling brought an immediate vow from the Biden administration and the drug's maker to appeal the matter in federal court.
Attorney General Merrick Garland said the Justice Department would ask the appeals court to stay the ban by Kacsmaryk, an ultraconservative Donald Trump appointee, until the case is finally resolved.
If the Texas ruling holds, it would complicate matters not just in the states now banning or sharply limiting abortions, but also in those where the procedure remains legal.
- Widely used -
Mifepristone has been used as part of a two-drug regimen by 5.6 million women since 2000.
But adding to the uncertainty and increasing the odds the matter ends up before the Supreme Court was a contradictory ruling from a Washington state judge that came just hours after Kacsmaryk's.
District Judge Thomas Rice, a Barack Obama appointee, ruled in a separate case -- brought by several states where abortion is legal -- that mifepristone is "safe and legal" and that the FDA must preserve access to it in more than a dozen states.
For now the drug remains legal, Alexis McGill Johnson, the head of Planned Parenthood, one of the largest pro-abortion groups in the country, said Friday.
Several abortion clinics also said Friday that they would continue using mifepristone until ordered not to by the FDA, US media reported.
Kacsmaryk paused the effect of his ruling for a week, allowing time for the administration and drugmaker Danco Laboratories to file before the US Fifth Circuit Court of Appeals in Louisiana, which hears cases from Texas.
The Justice Department is still reviewing Rice's ruling, Garland said in a statement.
- 'Remains safe' -
Given the sharply conflicting court rulings, the Justice Department might opt to take the case directly to the Supreme Court and not wait for the Fifth Circuit to act.
The high court could decide to take up the case on an emergency basis, which would require making room in an already crowded agenda at the end of the current term.
In that case, the court -- with six conservative justices outnumbering the three liberals -- could hear the case within days, or weeks, but sometime before the current session ends on June 30.
Chief Justice John Roberts, a conservative, is deeply protective of the image of the institution, and he might be expected to vote with the three liberals in favor of mifepristone. The additional vote of one other conservative could provide a majority for the drug.
The court's ruling last June to overturn the longstanding Roe v. Wade decision protecting abortion rights shifted considerable attention to medication abortions.
Most of them involve mifepristone in a two-drug regimen. A patient first takes a mifepristone pill to end the pregnancy, then a day later takes the drug misoprostol to induce contractions that expel the embryo or fetus.
Misoprostol can be used on its own to cause abortions, but the two-step procedure is considered more effective and can be more painful.
More than half of abortions in the US are done with medication.
Kacsmaryk, in his ruling, said the two-drug regimen had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.
But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective.
Michigan Governor Gretchen Whitmer, a Democrat, tweeted:
"Despite this ruling, I want to be clear: abortion, including medication abortion, remains safe and legal in the state of Michigan."
Women's March, which has been organizing organizing major women's rights demonstrations in recent years, called for a nationwide rally defending abortion rights for April 15.
A.Malone--AMWN